363 related articles for article (PubMed ID: 1445269)
21. Primary structure and functional characterization of rat C5a: an anaphylatoxin with unusually high potency.
Cui L; Carney DF; Hugli TE
Protein Sci; 1994 Aug; 3(8):1169-77. PubMed ID: 7987212
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the C5a receptor on guinea pig platelets.
Kretzschmar T; Kahl K; Rech K; Bautsch W; Köhl J; Bitter-Suermann D
Immunobiology; 1991 Nov; 183(5):418-32. PubMed ID: 1786990
[TBL] [Abstract][Full Text] [Related]
23. Biochemistry and biology of anaphylatoxins.
Hugli TE
Complement; 1986; 3(3):111-27. PubMed ID: 3542363
[TBL] [Abstract][Full Text] [Related]
24. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells.
el-Lati SG; Dahinden CA; Church MK
J Invest Dermatol; 1994 May; 102(5):803-6. PubMed ID: 7513741
[TBL] [Abstract][Full Text] [Related]
25. Evolution of anaphylatoxins, their diversity and novel roles in innate immunity: insights from the study of fish complement.
Sunyer JO; Boshra H; Li J
Vet Immunol Immunopathol; 2005 Oct; 108(1-2):77-89. PubMed ID: 16112742
[TBL] [Abstract][Full Text] [Related]
26. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.
Schäfer B; Piliponsky AM; Oka T; Song CH; Gerard NP; Gerard C; Tsai M; Kalesnikoff J; Galli SJ
J Allergy Clin Immunol; 2013 Feb; 131(2):541-8.e1-9. PubMed ID: 22728083
[TBL] [Abstract][Full Text] [Related]
27. Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines.
Johswich K; Martin M; Thalmann J; Rheinheimer C; Monk PN; Klos A
J Biol Chem; 2006 Dec; 281(51):39088-95. PubMed ID: 17068344
[TBL] [Abstract][Full Text] [Related]
28. Preservation of antimicrobial properties of complement peptide C3a, from invertebrates to humans.
Pasupuleti M; Walse B; Nordahl EA; Mörgelin M; Malmsten M; Schmidtchen A
J Biol Chem; 2007 Jan; 282(4):2520-8. PubMed ID: 17132627
[TBL] [Abstract][Full Text] [Related]
29. Functional activities of synthetic anaphylatoxic peptides in widely used biological assays.
Kola A; Klos A; Bautsch W; Kretzschmar T; Köhl J
Clin Exp Immunol; 1992 May; 88(2):368-72. PubMed ID: 1572104
[TBL] [Abstract][Full Text] [Related]
30. Active recombinant C3a of human anaphylatoxin produced in Escherichia coli.
Fukuoka Y; Yasui A; Tachibana T
Biochem Biophys Res Commun; 1991 Mar; 175(3):1131-8. PubMed ID: 2025244
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins.
West PW; Bahri R; Garcia-Rodriguez KM; Sweetland G; Wileman G; Shah R; Montero A; Rapley L; Bulfone-Paus S
Front Immunol; 2020; 11():615236. PubMed ID: 33597949
[TBL] [Abstract][Full Text] [Related]
32. Nucleotide and corrected amino acid sequence of the functional recombinant rat anaphylatoxin C5a.
Rothermel E; Rolf O; Götze O; Zwirner J
Biochim Biophys Acta; 1997 Mar; 1351(1-2):9-12. PubMed ID: 9116048
[TBL] [Abstract][Full Text] [Related]
33. Cloning and functional expression of the canine anaphylatoxin C5a receptor. Evidence for high interspecies variability.
Perret JJ; Raspe E; Vassart G; Parmentier M
Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):911-7. PubMed ID: 1472004
[TBL] [Abstract][Full Text] [Related]
34. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells.
Boulay F; Mery L; Tardif M; Brouchon L; Vignais P
Biochemistry; 1991 Mar; 30(12):2993-9. PubMed ID: 2007135
[TBL] [Abstract][Full Text] [Related]
35. Complement factors and their receptors.
Ember JA; Hugli TE
Immunopharmacology; 1997 Dec; 38(1-2):3-15. PubMed ID: 9476110
[TBL] [Abstract][Full Text] [Related]
36. Anaphylatoxin-induced neutrophil chemotaxis and aggregation. Limited aggregation and specific desensitization induced by human C3a and synthetic C3a octapeptides.
Nagata S; Glovsky MM; Kunkel SL
Int Arch Allergy Appl Immunol; 1987; 82(1):4-9. PubMed ID: 3492446
[TBL] [Abstract][Full Text] [Related]
37. Demonstration of a specific C3a receptor on guinea pig platelets.
Fukuoka Y; Hugli TE
J Immunol; 1988 May; 140(10):3496-501. PubMed ID: 3283237
[TBL] [Abstract][Full Text] [Related]
38. Identification of casoxin C, an ileum-contracting peptide derived from bovine kappa-casein, as an agonist for C3a receptors.
Takahashi M; Moriguchi S; Suganuma H; Shiota A; Tani F; Usui H; Kurahashi K; Sasaki R; Yoshikawa M
Peptides; 1997; 18(3):329-36. PubMed ID: 9145417
[TBL] [Abstract][Full Text] [Related]
39. Anaphylactic actions of platelet-activating factor.
Stimler NP; Bloor CM; Hugli TE; Wykle RL; McCall CE; O'Flaherty JT
Am J Pathol; 1981 Oct; 105(1):64-9. PubMed ID: 6975043
[TBL] [Abstract][Full Text] [Related]
40. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells.
Shivshankar P; Li YD; Mueller-Ortiz SL; Wetsel RA
FASEB J; 2020 Jun; 34(6):7540-7560. PubMed ID: 32301538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
